Cover Image

Corrigendum: Decreased Risk of Anxiety in Diabetic Patients Receiving Glucagon-Like Peptide-1 Receptor Agonist: A Nationwide, Population-Based Cohort Study

Saved in:

Bibliographic Details
Main Authors:	Wen-Hsuan Tsai (Author), Fung-Chang Sung (Author), Lu-Ting Chiu (Author), Ying-Hsiu Shih (Author), Ming-Chieh Tsai (Author), Shu-I Wu (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Decreased Risk of Anxiety in Diabetic Patients Receiving Glucagon-like Peptide-1 Receptor Agonist: A Nationwide, Population-Based Cohort Study
by: Wen-Hsuan Tsai, et al.
Published: (2022)

Antiosteoporosis medications and cardiovascular disease: a population-based nationwide nested case-control study
by: Wen-Hsuan Tsai, et al.
Published: (2023)

Risk of major adverse limb events in patients with type 2 diabetes mellitus receiving sodium glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists: A population-based retrospective cohort study
by: Yen-Chieh Lee, et al.
Published: (2022)

Statin Therapy for Hyperlipidemic Patients With Chronic Kidney Disease and End-Stage Renal Disease: A Retrospective Cohort Study Based on 925,418 Adults in Taiwan
by: Fung-Chang Sung, et al.
Published: (2022)

Real-World Comparative Evaluation of Add-On Glucagon-like Peptide 1 Receptor Agonist in Type 2 Diabetes Treated with or without Insulin
by: Hsuan-Wen Chou, et al.
Published: (2022)

Increased low back pain risk in nurses with high workload for patient care: A questionnaire survey
by: Shwn-Huey Shieh, et al.
Published: (2016)

Pharmacoeconomic characteristics of agonists of receptors for glucagon-like peptide-1 and medicines on their base
by: I. N. Dyakov, et al.
Published: (2021)

Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes
by: Seungah Lee, et al.
Published: (2017)

Decreased CD11c‐positive dendritic cells in the tumor microenvironment predict double‐hit/triple‐hit genotype and survival in diffuse large B‐cell lymphoma
by: Chang‐Tsu Yuan, et al.
Published: (2022)

Glucagon-like peptide receptor agonists attenuate advanced glycation end products-induced inflammation in rat mesangial cells
by: Jui-Ting Chang, et al.
Published: (2017)

Characteristics of patients with endometrial hyperplasia under different air quality index conditions
by: Fung-Wei Chang, et al.
Published: (2019)

Increased Risk of Tourette Syndrome with Leukotriene Modifier Use in Children with Allergic Diseases and Asthma: A Nationwide Population-Based Study
by: Min-Lan Tsai, et al.
Published: (2022)

Antepartum urinary tract infection and postpartum depression in Taiwan - a nationwide population-based study
by: Jui-Ming Liu, et al.
Published: (2018)

Glucagon-like peptide-1 (GLP-1) agonists in the treatment of obesity
by: Magdalena Mazurek, et al.
Published: (2023)

Clinical significance of pharmacogenomic studies in tardive dyskinesia associated with patients with psychiatric disorders
by: Chang FC, et al.
Published: (2014)

Neurological and endocrinological manifestations of 49 children with intracranial pure germinoma at initial diagnosis in Taiwan
by: Hsin-Yuan Chang, et al.
Published: (2021)

Medical Costs of Stroke Care Between Women With and Without Dysmenorrhea: A Population-Based Comparison
by: Ya-Wen Lin, et al.
Published: (2021)

Glucagon-like peptide-1 receptor agonists as add-on therapy to insulin for type 1 diabetes mellitus
by: Xinrui Tan, et al.
Published: (2023)

Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease
by: Laurie L. Baggio, et al.
Published: (2021)

Glucagon-like peptide-1 receptor agonists and derivatives in the treatment of obesity - review
by: Michal Rabenda, et al.
Published: (2024)

Metabolic syndrome is associated with change in subclinical arterial stiffness - A community-based Taichung Community Health Study
by: Lin Wen-Yuan, et al.
Published: (2011)

Water outage increases the risk of gastroenteritis and eyes and skin diseases
by: Chou Chang-Hung, et al.
Published: (2011)

Corrigendum to "Cutaneous Plasmacytosis with Perineural Involvement"
by: Elizabeth A. Brezinski, et al.
Published: (2016)

The role of glucagon-like peptide-1 receptor agonists (GLP1-RAs) in the management of the hypertensive patient with metabolic syndrome: a position paper from the Korean society of hypertension
by: Hae Young Lee, et al.
Published: (2024)

Effect of Glucagon-like peptide-1 receptor agonists on dyslipidemia in type 2 diabetes
by: Elizabeth A. Cristiano, et al.
Published: (2020)

Impact of Glucagon-like Peptide-1 Receptor Agonists on Intestinal Epithelial Cell Barrier
by: Takizawa Y., et al.
Published: (2024)

The Therapeutic Potential of Glucagon-like Peptide 1 Receptor Agonists in Traumatic Brain Injury
by: Anja Harej Hrkać, et al.
Published: (2024)

Amelioration of muscle wasting by glucagon‐like peptide‐1 receptor agonist in muscle atrophy
by: Yeonhee Hong, et al.
Published: (2019)

The Chinese medicine JC-001 enhances the chemosensitivity of Lewis lung tumors to cisplatin by modulating the immune response
by: Meng-Hsien Chuang, et al.
Published: (2017)

Respiratory Outcomes of Insulin Use in Patients with COPD: A Nationwide Population-Based Cohort Study
by: Fu-Shun Yen, et al.
Published: (2023)

Effects of glucagon-like peptide 1 receptor agonists on comorbidities in older patients with diabetes mellitus
by: Olusola F. Onoviran, et al.
Published: (2019)

Glucagon-like peptide-1 receptor agonists for treatment of diabetes and obesity: advantage of oral delivery
by: R. R. C. New, et al.
Published: (2024)

Hyperextension of Cervical Spines in Face Presentation Diagnosed by Fetal Sonography
by: Chang-Cheng Wu, et al.
Published: (2005)

Reappraisal of the Etiology of Extracorpuscular Non-Autoimmune Acquired Hemolytic Anemia in 2657 Hospitalized Patients with Non-Neoplastic Disease
by: Victor C. Kok, et al.
Published: (2014)

Reappraisal of the Etiology of Extracorpuscular Non-Autoimmune Acquired Hemolytic Anemia in 2657 Hospitalized Patients with Non-Neoplastic Disease
by: Victor C. Kok, et al.
Published: (2014)

A cohort study evaluating the risk of stroke associated with long-term exposure to ambient fine particulate matter in Taiwan
by: Pei-Chun Chen, et al.
Published: (2022)

Effectiveness of high-intensity focused ultrasound combined with gonadotropin-releasing hormone agonist or combined with levonorgestrel-releasing intrauterine system for adenomyosis: A systematic review and meta-analysis
by: Yi-Liang Lee, et al.
Published: (2024)

The economic side of an oral sugar lowering therapy intensification by glucagon-like peptidt-1 receptor agonists
by: S. K. Zyryanov, et al.
Published: (2022)

Laparoscopy-assisted Robotic Myomectomy Using the DA Vinci System
by: Shih-Peng Mao, et al.
Published: (2007)

Glucagon-Like Peptide-1 Receptor Agonists and Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity/Metabolic Syndrome, Prediabetes/Diabetes and Non-Alcoholic Fatty Liver Disease-Current Evidence
by: Emir M. Muzurović MD, MM, et al.
Published: (2022)